Previous 10 | Next 10 |
Enables Immutep to initiate its AIPAC-002 study, in metastatic breast cancer AIPAC-002 to expedite the possible use of efti for patients in the US SYDNEY, Australia, March 09, 2020 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep” or “t...
SHANGHAI , Feb. 24, 2020 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, congratulates its strategic partner Immutep, a biot...
Groupon (NASDAQ: GRPN ) -31% on Q4 earnings . More news on: Groupon, Inc., Scientific Games Corporation, Blue Apron Holdings, Inc., Stocks on the move, , Read more ...
Encouraging Overall Response Rates (ORR) reported from stage 1 Parts A and C, with responses in 47% of 1 st line non-small cell lung cancer (NSCLC) patients and already 33% of 2 nd line head and neck squamous cell carcinoma (HNSCC) patients NSCLC responses are seen across all three PD-L...
SYDNEY, Australia, Feb. 04, 2020 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep” or “the Company”), a biotechnology company developing novel immunotherapy treatments for cancer and autoimmune diseases, advises that more mature interim TACT...
Aimmune Gets a Boost as FDA Green Signals Allergy Medication Aimmune Therapeutics ( AIMT ) received FDA nod for its peanut allergy medication Palforzia. This orally administered medication aims to mitigate allergic reactions caused by exposure to peanuts. While it is not designed to be an ...
Thinly traded nano cap Immutep Limited ( IMMP +19% ) is up on a 14x surge in volume on the heels of its pipeline update including several important near-term data readouts. More news on: Immutep Limited, Healthcare stocks news, Stocks on the move, Read more ...
5 Penny Stocks To Watch Before Friday This week we’ve seen a crazy mix of health concerns and economic uncertainty push the market all over the place. However, following the initial drop, the market has started to recover. Lack of volatility can make investors look for places where ther...
First progression-free survival (“PFS”) data expected from late-stage Phase IIb metastatic breast cancer study, AIPAC, in March 2020 More mature data expected from TACTI-002 in February 2020 Sufficiently funded to deliver key upcoming catalysts SYDNEY, Australia, Jan. 2...
Recruitment completed for stage 1 of Part C of TACTI-002 trial, for patients with second line Head and Neck Squamous Cell Carcinoma (HNSCC) Part C has been expanded to include an additional 19 HNSCC patients, creating stage 2 of Part C Follows Data Monitoring Committee (DMC) decision af...
News, Short Squeeze, Breakout and More Instantly...
Media Release Final discussion with the FDA, successfully concluding the regulatory preparations for the TACTI-004 Phase III trial design to evaluate efti in combination with KEYTRUDA ® (pembrolizumab), MSD’s anti-PD-1 therapy, and standard chemotherapy in first-...
Media Release Study expected to enrol first participants during Q3 CY2024 SYDNEY, AUSTRALIA, July 17, 2024 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep” or “the Company”), a clinical-stage biotechnology company developing no...
2024-07-12 10:45:04 ET QuantumScape Corp (QS) QS is trading UP for the last 5 days, and it at trading at $7.84 with volume of 22,322,158 and a one day change of $0.78 (10.98%). QuantumScape Corp has a 52-week low of 4.67 and a 52-week high of $13.86. The business's 50-day moving ave...